Orgenesis: Why Orgenesis (ORGS) Stock Is Down 23% Today
Orgenesis shares are trading lower by 23% during Monday's session. The company announced a 1-for-10 reverse stock split. read more
Read full article »
Orgenesis is a Maryland-based biotechnology company that researches and develops cell and gene therapies for the treatment of a wide range of diseases.
Read more